Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Gilead Sciences Inc. Healthcare Policy PAC
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Trending
+
Community
Patient Daily News Service
| May 7, 2024
National Breathe Free Sinus and Allergy raises $110,000 for dog rescue organization
+
Pharmaceuticals
Patient Daily
| May 3, 2024
Rice, Baylor centers award joint research seed grants
+
Pharmaceuticals
Patient Daily
| May 8, 2024
American Lung Association Recognized for Innovative Work to Help People with Advanced Lung Disease
+
Pharmaceuticals
Patient Daily
| May 2, 2024
Orlando Turns Turquoise for Lung Cancer Action Week